SHARE THIS VIDEO —
Biogen will seek federal approval for new Alzheimer’s drug
Drugmaker Biogen says it will seek federal approval for a medicine to treat Alzheimer’s disease in its early stages. Biogen says a new analysis suggests that the drug can reduce the loss of thinking skills when taken at the highest dose.